These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6217174)

  • 21. Alloreactive T cells: expression of HLA-D antigens, stimulation of autologous MLR, and possible immunoregulatory function.
    Suciu-Foca N; Rohowsky C; Coburn C; Reed E; Khan R; Lewison A
    Hum Immunol; 1981 Dec; 3(4):301-12. PubMed ID: 6460016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Typing for MLC determinants: methods and applications.
    Thomsen M; Ryder LP; Svejgaard A
    Scand J Immunol; 1976 Jun; Suppl 5():157-74. PubMed ID: 79216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for subtypic determinants in the HLA-DW3 cluster.
    Niese D; Grosse-Wilde H; Dupont B; Du Toit E; Johannsen R; Suciu-Foca N; Stroehmann I; Rittner C
    Hum Genet; 1978 Jul; 43(1):23-30. PubMed ID: 78887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between HLA-D/DR associated primed lymphocyte typing (PLT) defined DP-antigens, HLA-D and HLA-DR antigens.
    Morling N; Jakobsen BK; Platz P; Ryder LP; Svejgaard A; Thomsen M
    Tissue Antigens; 1981; 17(4):421-7. PubMed ID: 7036403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitation of HLA-D differences.
    Suciu-Foca N; Rubinstein P; Susinno E; Broell J; Weiner J; Reemtsma K
    Tissue Antigens; 1978 Aug; 12(2):94-105. PubMed ID: 81541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intra HLA-D/DR region recombinant detected by primed lymphocyte typing (PLT).
    Jakobsen BK; Kristensen T; Lamm LU; Morling N; Bruun-Petersen G; Platz P; Ryder LP; Svejgaard A
    Tissue Antigens; 1983 Aug; 22(2):123-33. PubMed ID: 6578608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of HLA-D specific primed lymphocyte typing (PLT) cells and cross-reactions of PLT-cells primed with homozygous typing cells.
    Morling N; Platz P; Ryder LP; Svejgaard A; Thomsen M
    Tissue Antigens; 1980 Feb; 15(2):137-51. PubMed ID: 12735314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-DR beta III and HLA-DP induce comparable proliferation in primary mixed lymphocyte culture.
    Schroeijers WE; de Koster HS; van Rood JJ; Termijtelen A
    Tissue Antigens; 1988 Sep; 32(3):145-9. PubMed ID: 2464203
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Definition of DW8.2 by primary and secondary mixed lymphocyte cultures.
    Herrera F; Layrisse Z; Carreño B; Quintero M; Honeyman M; Mickelson EM; Tsuji K
    Hum Immunol; 1985 Jan; 12(1):9-21. PubMed ID: 3156107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Genetic control of mixed lymphocyte culture].
    Hajek-Rosenmayr A
    Wien Klin Wochenschr; 1980 Dec; 92(23):834-40. PubMed ID: 6242847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An HLA-DR/DP recombinant family involving DPw6. Evidence for cross-reactivity between DPw6 and GNN2B.
    Odum N; Hartzman R; Jakobsen BK; Morling N; Platz P; Robbins FM; Ryder LP; Shaw S; Svejgaard A
    Tissue Antigens; 1986 Jan; 27(1):44-52. PubMed ID: 3082036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulation in primary MLR caused by a PLT defined non-HLA-D/DR determinant, EP1.
    Holter W; Morling N
    Tissue Antigens; 1983 Jul; 22(1):42-8. PubMed ID: 6193606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-D-DR relationships: PLT studies of HLA-D specificities associated with DR1, DR2, and DR4.
    Suciu-Foca N; Godfrey M; Khan R
    Hum Immunol; 1981 Jul; 2(4):295-304. PubMed ID: 6168618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell membrane polymorphisms coded for in the HLA-D/DR region. I. Relation between D and DR.
    Schreuder GM; van Leeuwen A; Termijtelen A; Parlevliet J; D'Amaro J; van Rood JJ
    Hum Immunol; 1982 Jul; 4(4):301-12. PubMed ID: 6181036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reactions of primed lymphocytes (PLT) and their genetic determination (author's transl)].
    Hajek-Rosenmayr A
    Wien Klin Wochenschr; 1982 Jan; 94(1):13-9. PubMed ID: 6177103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HLA and MLC typing in patients with Hodgkin's disease.
    Hansen JA; Young CW; Whitsett C; Case DC; Jersild C; Good RA; Dupont B
    Prog Clin Biol Res; 1977; 16():217-27. PubMed ID: 143667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA gene and haplotype frequencies in the North American population: the National Marrow Donor Program Donor Registry.
    Mori M; Beatty PG; Graves M; Boucher KM; Milford EL
    Transplantation; 1997 Oct; 64(7):1017-27. PubMed ID: 9381524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China.
    Trachtenberg E; Vinson M; Hayes E; Hsu YM; Houtchens K; Erlich H; Klitz W; Hsia Y; Hollenbach J
    Tissue Antigens; 2007 Dec; 70(6):455-63. PubMed ID: 17900288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the mixed lymphocyte culture (MLC) reaction in marrow donor selection: matching for transplants from related haploidentical donors.
    Mickelson EM; Guthrie LA; Etzioni R; Anasetti C; Martin PJ; Hansen JA
    Tissue Antigens; 1994 Aug; 44(2):83-92. PubMed ID: 7817382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogenic proliferative and cytotoxic responses.
    Shaw S; Johnson AH; Shearer GM
    J Exp Med; 1980 Sep; 152(3):565-80. PubMed ID: 6967946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.